CompletedPhase 2NCT00584844
Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine
Studying Tularemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- U.S. Army Medical Research and Development Command
- Principal Investigator
- Mark Goldberg, MDUSAMRIID Medical Division
- Intervention
- Live F tularensis Vaccine(biological)
- Enrollment
- 484 target
- Eligibility
- 17-65 years · All sexes
- Timeline
- 2004 – 2013
Study locations (1)
- U.S. Army Medical Research Institute of Infectious Diseases, Fort Deterick, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00584844 on ClinicalTrials.gov